Media Summary: Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at Heather A. Wakelee, MD, Stanford University, Stanford, CA, discusses non-small cell Bob T. Li, MD, MPH, Memorial Sloan Kettering Cancer Center, New York, NY, discusses findings from the Phase I/II

Asco 2021 Lung Recap Codebreak - Detailed Analysis & Overview

Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at Heather A. Wakelee, MD, Stanford University, Stanford, CA, discusses non-small cell Bob T. Li, MD, MPH, Memorial Sloan Kettering Cancer Center, New York, NY, discusses findings from the Phase I/II Listen as experts discuss the impact of melanoma abstracts from this year's

Photo Gallery

ASCO 2021 Lung Recap: CodeBreak 100: Sotorasib in KRAS G12C Mutation
ASCO 2021 Lung Recap: Lurbinectedin in Small Cell Lung Cancer and the Failed Atlantis Trial
ASCO 2021 Lung Recap: Circulatory Tumor DNA
2021 ASCO Direct Denver | Metastatic Lung Cancer Summary | Dr. Jose Pacheco
ASCO 2021 Lung Recap: MYLUNG Consortium: Overall Biomarker Testing
ASCO 2021 Lung Recap: FDA Analysis of Immunotherapy With or Without Chemo in Adv NSCLC and Low PDL-1
Axiom ASCO 2021 Town Hall on Lung Cancer
ASCO 2021 Lung Recap: Poseidon Trial: Durvalumab +/- Tremelimumab vs. Chemo Alone
NSCLC highlights from ASCO 2021
ASCO 2021 Lung Recap: IMpower010: Atezolizumab after Chemo in Non-Small Cell Lung Cancer
CodeBreaK 100: detecting mechanisms of intrinsic resistance by ctDNA
ASCO 2021 Lung Recap: Surgical Outcomes & Checkmate 816: Nivolumab in Early Stage NSCLC
View Detailed Profile
ASCO 2021 Lung Recap: CodeBreak 100: Sotorasib in KRAS G12C Mutation

ASCO 2021 Lung Recap: CodeBreak 100: Sotorasib in KRAS G12C Mutation

Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at

ASCO 2021 Lung Recap: Lurbinectedin in Small Cell Lung Cancer and the Failed Atlantis Trial

ASCO 2021 Lung Recap: Lurbinectedin in Small Cell Lung Cancer and the Failed Atlantis Trial

Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at

ASCO 2021 Lung Recap: Circulatory Tumor DNA

ASCO 2021 Lung Recap: Circulatory Tumor DNA

Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at

2021 ASCO Direct Denver | Metastatic Lung Cancer Summary | Dr. Jose Pacheco

2021 ASCO Direct Denver | Metastatic Lung Cancer Summary | Dr. Jose Pacheco

At the

ASCO 2021 Lung Recap: MYLUNG Consortium: Overall Biomarker Testing

ASCO 2021 Lung Recap: MYLUNG Consortium: Overall Biomarker Testing

Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at

ASCO 2021 Lung Recap: FDA Analysis of Immunotherapy With or Without Chemo in Adv NSCLC and Low PDL-1

ASCO 2021 Lung Recap: FDA Analysis of Immunotherapy With or Without Chemo in Adv NSCLC and Low PDL-1

Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at

Axiom ASCO 2021 Town Hall on Lung Cancer

Axiom ASCO 2021 Town Hall on Lung Cancer

... super delighted to conclude our

ASCO 2021 Lung Recap: Poseidon Trial: Durvalumab +/- Tremelimumab vs. Chemo Alone

ASCO 2021 Lung Recap: Poseidon Trial: Durvalumab +/- Tremelimumab vs. Chemo Alone

Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at

NSCLC highlights from ASCO 2021

NSCLC highlights from ASCO 2021

Heather A. Wakelee, MD, Stanford University, Stanford, CA, discusses non-small cell

ASCO 2021 Lung Recap: IMpower010: Atezolizumab after Chemo in Non-Small Cell Lung Cancer

ASCO 2021 Lung Recap: IMpower010: Atezolizumab after Chemo in Non-Small Cell Lung Cancer

Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at

CodeBreaK 100: detecting mechanisms of intrinsic resistance by ctDNA

CodeBreaK 100: detecting mechanisms of intrinsic resistance by ctDNA

Bob T. Li, MD, MPH, Memorial Sloan Kettering Cancer Center, New York, NY, discusses findings from the Phase I/II

ASCO 2021 Lung Recap: Surgical Outcomes & Checkmate 816: Nivolumab in Early Stage NSCLC

ASCO 2021 Lung Recap: Surgical Outcomes & Checkmate 816: Nivolumab in Early Stage NSCLC

Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at

ASCO 2021 Clinical Panel Series - Lung Cancer

ASCO 2021 Clinical Panel Series - Lung Cancer

Listen as experts discuss the impact of melanoma abstracts from this year's